{
  "docId": "019de073-f021-770f-8b07-e7c119465e03",
  "docSlug": "6227ea40012eb82f352898e4936ae469",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 48 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 23,
  "pageCount": 48,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "key_messages",
  "function": "prioritize",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a numbered list format to outline corporate strategy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-f021-770f-8b07-e7c119465e03/23",
  "deckHref": "/decks/019de073-f021-770f-8b07-e7c119465e03",
  "deckJsonHref": "/decks/019de073-f021-770f-8b07-e7c119465e03.json",
  "deckAnchorHref": "/decks/019de073-f021-770f-8b07-e7c119465e03#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.5,
        "x": 0.46,
        "y": 0.18
      },
      "kind": "list",
      "text": "Accelerate growth engines of Salix and International; Maximize cash-generation of Diversified Products; Drive growth in Solta Medical; Advance our R&D pipeline; Establish a high performance culture; Utilize cash to improve leverage; Progress Bausch + Lomb distribution; Monetize ~8.7% of Bausch + Lomb; Drive towards target net leverage ratio ~6.5x-6.7x",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "163c7b64-cb8b-4460-aae2-42d1bf9bda43",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.42,
        "x": 0.04,
        "y": 0.17
      },
      "kind": "list",
      "text": "1. Drive growth through operational excellence across the enterprise\n2. Intensify focus and operating rigor behind R&D and business development\n3. Cultivate a high-performance, results-oriented culture\n4. Progress strategic alternatives",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43afe8a9-d9ab-4c29-bdf8-a1b6a5ed8437",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.04,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "1.See Slide 2 for further information on forward-looking statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb26a6fe-439f-4d7e-ab25-c2b468374e87",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "2022 Bausch Pharma + Solta priorities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef454b77-833d-4a64-bb72-bcd8c16de265",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "26703f9d-273a-414f-b0a7-f086afc661b5",
      "evidence": "The slide contains a list/bullet with priorities",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "566d8e2f-c1d3-474d-961c-399416cde91d",
      "evidence": "Numbered list of strategic priorities",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 24,
      "from": 21,
      "beatId": "a4dc27d9-5cba-4968-8961-8cf39f51c2ee",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The document outlines actions taken and the path forward to encourage the audience to take action.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "05a42e5d-33da-405b-8ece-2b28299f64ad",
      "evidence": "The document implies that not taking action would result in missed opportunities and decreased financial performance.",
      "position": 0,
      "objective": "To highlight the cost of inaction and the benefits of the company's strategy",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}